封面
市场调查报告书
商品编码
2008105

猴痘治疗市场:依治疗方法、给药途径、通路及地区划分

Monkeypox Treatment Market, By Treatment Type, By Route of Administration, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2026 年,猴痘治疗市场规模将达到 1.348 亿美元,到 2033 年将达到 4.224 亿美元。预计从 2026 年到 2033 年,该市场将以 18.5% 的复合年增长率成长。

分析范围 分析详情
基准年 2025 市场规模(2026 年) 1.348亿美元
效能数据 2020-2024 预测期 2026-2033
预测期(2026-2033 年)复合年增长率 18.50% 预计金额(2033 年) 4.224亿美元

猴痘是一种罕见疾病,由猴痘病毒感染引起。猴痘病毒和天花病毒属于同一病毒科。然而,猴痘的传染性不如天花强。此外,猴痘的症状相对较轻,通常不会致命。猴痘的主要症状是皮疹,皮疹可能出现在生殖器或其周围。

猴痘于1958年被发现,当时一群用于研究的猴子集体爆发了两次类似天花的症状。虽然这种疾病可以透过与感染者皮肤接触传播,但感染者与囓齿动物之间的接触才是主要的传播途径。猴痘病毒有两种类型,一种起源于中非,另一种起源于西非。

过去,大多数猴痘感染者要么居住在中非或西非的特定地区,要么到访过这些地区,要么接触过从这些地区进口的受感染动物。在2022年的疫情中,包括美国在内的多个国家的居住者都确诊感染了猴痘。

市场动态

2022年8月4日,美国卫生与公共服务部宣布猴痘疫情构成公共卫生紧急事件。这加速了对猴痘疫苗和更有效治疗方法的需求。猴痘感染疾病的蔓延以及对疫苗和新治疗方法需求的增加预计将推动全球猴痘治疗市场的成长。例如,根据世界卫生组织的数据,截至2022年6月,在2022年1月1日至6月22日期间,世卫组织五大区域的50个国家和地区共报告了3413例实验室确诊病例和1例死亡病例。此外,来自非洲、美洲、东地中海和西太平洋等区域的8个国家报告了1310例新增病例。 2022年第二季度,尼日利亚报告了1例死亡病例。

本报告的主要特点

  • 本报告对全球猴痘治疗市场进行了详细分析,包括预测期(2022-2030 年)的市场规模和复合年增长率,其中 2021 年为基准年。
  • 此外,它还确定了每个细分市场的潜在商机,并描述了该市场中一系列有吸引力的投资提案。
  • 此外,它还提供了有关市场驱动因素和限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
  • 本文根据以下参数,介绍了全球猴痘治疗市场主要企业的概况:公司概况、产品系列、主要亮点、财务表现和策略。
  • 本报告中的见解将使负责人和企业经营团队能够就未来的产品发布、产品线更新、市场扩张和行销策略做出明智的决策。
  • 《全球猴痘治疗市场》报告面向该行业的众多相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过分析全球猴痘治疗市场中使用的各种策略矩阵来促进决策。

目录

第一章:分析目标与假设

  • 分析目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章:市场动态、监管与趋势分析

  • 市场动态
  • 促进因素
  • 抑制因子
  • 市场机会
  • 影响分析
  • 市场趋势
  • 主要进展
  • 产品核准
  • 商业伙伴关係、企业合併
  • 监理情势
  • PEST分析
  • 波特五力分析
  • 流行病学
  • 固体管道分析

第四章 猴痘治疗市场:依治疗方法(2026-2033 年)

  • 预防医学(疫苗)
  • 治疗药物(替可比利马、布林西多福韦、西多福韦)

第五章:猴痘治疗市场:依给药途径划分(2026-2033 年)

  • 口服
  • 注射

第六章:猴痘治疗市场:依通路划分(2026-2033 年)

  • 零售药房
  • 医院药房
  • 网路药房

第七章 猴痘治疗市场:依地区划分(2026-2033 年)

  • 北美洲
    • 我们
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 法国
    • 西班牙
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韩国
    • 其他亚太地区
  • 中东
    • GCC
    • 以色列
    • 其他中东国家
  • 非洲
    • 北非
    • 中非
    • 南非

第八章 竞争情势

  • 热图分析
  • 市占率分析
  • 公司简介
    • SIGA Technologies Inc.
    • Bavarian Nordic
    • Sanofi SA.
    • Emcure Pharma
    • Jinan Jinda Pharmaceutical Chemistry Co., Ltd.

第九章

  • 参考
  • 分析方法
  • 关于 Coherent Market Insights
简介目录
Product Code: CMI5199

Monkeypox Treatment Market is estimated to be valued at USD 134.8 Mn in 2026 and is expected to reach USD 422.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 18.5% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 134.8 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 18.50% 2033 Value Projection: USD 422.4 Mn

A rare condition known as monkeypox is brought on by infection with the monkeypox virus. The smallpox virus and the monkeypox virus both belong to the same virus family. Monkey pox, however, is not as contagious as smallpox. Additionally, the illness has lesser symptoms and is typically not fatal. The major symptom of Monkeypox is rash that may be located on or near the genitals.

Two outbreaks of a condition resembling the pox that were occurring in groups of monkeys being used for research led to the discovery of monkeypox in 1958. Although, skin-to-skin contact with an infected person can sometimes spread the disease, rodent contact with infected humans accounts for the majority of its transmission. The monkeypox virus has two distinct types, one of which originated in Central Africa and the other in West Africa.

The majority of those who contracted monkeypox in the past either resided and visited specific regions of central or western Africa, or exposed to diseased animals imported from such regions. The disease has been identified in residents of several nations, including the U.S., during the 2022 outbreak.

Market Dynamics

The U.S. Department of Health and Human Services, on August 4 2022 declared monkeypox outbreak as a public health emergency. Due to which there is acceleration in the demand for vaccines and better treatment for monkeypox. Increase in the prevalence of monkeypox disease and increasing demand for vaccines and new treatment for monkeypox is expected to drive growth of the global monkeypox treatment market. For instance, in June 2022, according to the WHO, since 1 January to 22 June 2022, 3413 laboratory confirmed cases and one death have been reported to the WHO from 50 countries/territories in the five WHO Regions. Moreover, 1310 new cases have been reported in eight new countries from regions like African Region, Region of the Americas, Eastern Mediterranean Region and Western Pacific Region.One death was reported in Nigeria in the second quarter of 2022.

Key features of the study

  • This report provides an in-depth analysis of the global monkeypox treatment market, market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global monkeypox treatment market based on the following parameters - company highlights, types portfolio, key highlights, financial performance, and market strategies
  • Key companies covered as a part of this study include SIGA Technologies, Inc., Bavarian Nordic, Sanofi SA, and Emcure Pharma, Jinan Jinda Pharmaceutical Chemistry Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global monkeypox treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global monkeypox treatment market

Market Segmentation

  • By Treatment Type
    • Prophylactic (Vaccines)
    • Therapeutics (Tecovirimat, Brincidofovir, Cidofovir)
  • By Route of Administration
    • Oral
    • Injectable
  • By Distribution Channel
    • Retail Pharmacies
    • Hospital Pharmacies
    • Online Pharmacies
  • By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East & Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa
  • Key Players
    • SIGA Technologies Inc.
    • Bavarian Nordic
    • Sanofi SA.
    • Emcure Pharma
    • Jinan Jinda Pharmaceutical Chemistry Co., Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Treatment Type
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Product Approval
  • Collaboration/Merge/Acquisition
  • Regulatory Landscape
  • PEST Analysis
  • Porter's Five Forces Analysis
  • Epidemiology
  • Robust Pipeline Analysis

4. Monkeypox Treatment Market, By Treatment Type, 2026 - 2033, (US$ Million)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026- 2033
    • Segment Trends
  • Prophylactic (Vaccines)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
  • Therapeutics (Tecovirimat, Brincidofovir, Cidofovir)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)

5. Monkeypox Treatment Market, By Route of Administration, 2026 - 2033, (US$ Million)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
  • Injectable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)

6. Monkeypox Treatment Market, By Distribution Channel, 2026 - 2033, (US$ Million)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)

7. Monkeypox Treatment Market, By Region, 2026 - 2033, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2026-2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2026 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2026 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2026 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2026 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2026 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2026 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (US$ Million)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profile
    • SIGA Technologies Inc.
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Bavarian Nordic
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Sanofi SA.
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Emcure Pharma
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Jinan Jinda Pharmaceutical Chemistry Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About Us